27. [IF=5.062] Min Jiang et al."A novel polyphyllin I-based liposome delivery system sensitizes hepatic carcinoma to doxorubicin via cholesterol modulation."JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY.2022 Oct;:103925 26. [IF=4.412] Feng Su et al."Study of Chemical Compositions and Anticancer Effects of Paris polyphylla var. Chinensis Leaves."MOLECULES. 2022 Jan;27(9):2724 25. [IF=2.289] Zhou Shun et al."Anthelmintic efficacy of natural saponins against Gyrodactylus kobayashii in goldfish (Carassius auratus) and their 3D-QSAR analysis."Parasitol Res. 2021 Mar;120(3):1143-1150 24. [IF=3] Ming-Ming LIU et al."Polyphyllin I promotes cell death via suppressing UPR-mediated CHOP ubiquitination and degradation in non-small cell lung cancer."Chin J Nat Medicines. 2021 Apr;19:255 23. [IF=4.242] Shun Zhou et al."Anthelmintic efficacy of 35 herbal medicines against a monogenean parasite, Gyrodactylus kobayashii, infecting goldfish (Carassius auratus)."Aquaculture. 2020 May;521:734992 22. [IF=5.645] Bo Li et al."Organ-specific transcriptome sequencing and mining of genes involved in polyphyllin biosynthesis in Paris polyphylla."Ind Crop Prod. 2020 Nov;156:112775 21. [IF=2.439] Yunfei Zhang et al."Polyphyllin I inhibits growth and invasion of cisplatin-resistant gastric cancer cells by partially inhibiting CIP2A/PP2A/Akt signaling axis."J Pharmacol Sci. 2018 Jul;137:305 20. [IF=3.571] Xuewen Liu et al."Polyphyllin I inhibits invasion and epithelial-mesenchymal transition via CIP2A/PP2A/ERK signaling in prostate cancer."Int J Oncol. 2018 Sep;53(3):1279-1288 19. [IF=4.044] Feng Liu et al."Comparative analysis of proteomic and metabolomic profiles of different species of Paris."J Proteomics. 2019 May;200:11 18. [IF=4.072] Yan Yin et al."A cytochrome P450 monooxygenase responsible for the C-22 hydroxylation step in the Paris polyphylla steroidal saponin biosynthesis pathway."Phytochemistry. 2018 Dec;156:116 17. Liu, Feng, et al. "Comparative analysis of proteomic and metabolomic profiles of different species of Paris." Journal of proteomics 200 (2019): 11-27.https://doi.org/10.1016/j.jprot.2019.02.003 16. Liu, Feng, et al. "Comparative analysis of proteomic and metabolomic profiles of different species of Paris." Journal of proteomics 200 (2019): 11-27.https://doi.org/10.1016/j.jprot.2019.02.003 15. 彭鵬,金鑫,申杰,張?zhí)?向雨晨,劉瑩.重樓皂苷Ⅰ通過激活A(yù)MPK信號通路誘導(dǎo)非小細胞肺癌自噬的作用機制[J].湖北醫(yī)藥學(xué)院學(xué)報,2021,40(01):1-6+15+113. 14. 喻青青,樊旭,朱敏,郗雪艷,杜伯雨.重樓皂苷Ⅰ抗肝癌細胞作用的初步研究[J].中國免疫學(xué)雜志,2021,37(01):57-60+65. 13. 喻青青,李征遠,杜伯雨.重樓皂苷Ⅰ對肝癌細胞株Huh7、HepG2細胞增殖的影響研究[J].現(xiàn)代醫(yī)藥衛(wèi)生,2020,36(22):3551-3554. 12. 王仕寶 蘇瑩 李會寧 等. 響應(yīng)面法優(yōu)化重樓藥材中甾體皂苷的回流提取工藝研究[J]. 陜西農(nóng)業(yè)科學(xué) 2019 065(001):46-52. 11. 王仕寶 蔡艷妮 賈慧梅 等. HPLC法測定不同來源重樓藥材中7種甾體皂苷的含量[J]. 西北藥學(xué)雜志 2017 32(002):133-138. 10. 劉小芬, 黃秀植, 王河山. 閩產(chǎn)栽培重樓質(zhì)量評價分析[J]. 福建中醫(yī)藥, 2012, 43(005):53-55. 9. 劉小芬, 楊成梓, 黃澤豪,等. 重樓藥材性狀與4種皂苷含量分析[J]. 福建中醫(yī)藥, 2014, 045(001):53-56. 8. 向雨晨,楊銳,周彤,司淵,劉雪文,劉瑩.重樓皂苷Ⅰ通過下調(diào)CIP2A/PP2A/ERK信號通路抑制前列腺癌轉(zhuǎn)移的機制研究[J].湖北醫(yī)藥學(xué)院學(xué)報,2019,38(03):201-208. 7. 劉雪文,楊銳,趙紅艷,司淵,劉瑩,張?zhí)?重樓皂苷Ⅰ直接靶向STAT3抑制神經(jīng)膠質(zhì)瘤U251細胞增殖并誘導(dǎo)凋亡[J].腫瘤,2020,40(03):163-171. 6. 董凡赫,壽今豪,陳宇峰,張慧婷,樓云瑋,楊子鍵,張云.重樓皂苷I通過抑制自噬減輕磷酸三鈣磨損顆粒誘導(dǎo)成骨細胞損傷的實驗研究[J].中草藥,2020,51(09):2501-2508. 5. 劉佳, 張鵬, 宋發(fā)軍,等. 重樓地上部分四種重樓皂苷含量的分析[J]. 時珍國醫(yī)國藥, 2015, 026(005):1233-1235. 4. 錢蕾 陳陽. 七葉一枝花有效成分的提取工藝優(yōu)化[J]. 懷化學(xué)院學(xué)報 2019(5). 3. 葉菲菲 徐海波 汪春霞 等. 七葉一枝花中4種重樓皂苷同時測定與聚類分析[J]. 中成藥 2016 38(11):2413-2413. 2. 韓平 阮成江 王海明 等. HPLC法測定重樓塊根中4種重樓皂苷含量研究[J]. 大連民族大學(xué)學(xué)報 2018 20(001):17-20. 1. 劉佳 楊亞利 張鵬 等. 4種重樓不同部位4種重樓皂苷含量的分析[J]. 中國實驗方劑學(xué)雜志 2016年22卷16期 44-48頁 ISTIC PKU CSCD CA 2016.